CME Group Inc. (NASDAQ:CME) Shares Bought by Janney Capital Management LLC

Janney Capital Management LLC grew its stake in shares of CME Group Inc. (NASDAQ:CME) by 3.2% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 12,017 shares of the financial services provider’s stock after acquiring an additional 369 shares during the quarter. Janney Capital Management LLC’s holdings in CME Group were worth $2,652,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Salomon & Ludwin LLC acquired a new stake in CME Group during the 1st quarter worth approximately $28,000. Y.D. More Investments Ltd acquired a new stake in CME Group in the second quarter valued at approximately $36,000. McClarren Financial Advisors Inc. grew its position in CME Group by 66.1% in the second quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after acquiring an additional 78 shares in the last quarter. Asset Dedication LLC grew its position in CME Group by 515.2% in the second quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock valued at $40,000 after acquiring an additional 170 shares in the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. grew its position in CME Group by 62.2% in the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock valued at $43,000 after acquiring an additional 74 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on CME. Oppenheimer increased their price objective on shares of CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a research report on Thursday, October 24th. Piper Sandler increased their price objective on shares of CME Group from $240.00 to $250.00 and gave the company an “overweight” rating in a research report on Monday, October 28th. Keefe, Bruyette & Woods increased their price objective on shares of CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research report on Thursday, July 25th. TD Cowen assumed coverage on shares of CME Group in a research report on Thursday, September 26th. They issued a “hold” rating and a $221.00 price objective for the company. Finally, Deutsche Bank Aktiengesellschaft increased their target price on CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a research note on Thursday, August 15th. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $222.73.

CME Group Stock Performance

Shares of CME opened at $223.61 on Friday. The business’s fifty day moving average price is $220.69 and its 200 day moving average price is $209.48. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $230.36. The stock has a market capitalization of $80.52 billion, a PE ratio of 23.51, a price-to-earnings-growth ratio of 5.72 and a beta of 0.55. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The firm had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.59 billion. During the same period last year, the business posted $2.25 earnings per share. The firm’s revenue for the quarter was up 18.4% on a year-over-year basis. Equities research analysts forecast that CME Group Inc. will post 10.23 EPS for the current year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were given a $1.15 dividend. This represents a $4.60 annualized dividend and a yield of 2.06%. The ex-dividend date of this dividend was Monday, September 9th. CME Group’s dividend payout ratio is presently 48.37%.

Insiders Place Their Bets

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the sale, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the sale, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Lynne Fitzpatrick sold 754 shares of the stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the sale, the chief financial officer now directly owns 13,261 shares in the company, valued at $2,877,504.39. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 15,221 shares of company stock valued at $3,351,895 over the last three months. Company insiders own 0.30% of the company’s stock.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.